Long Focus Capital Management’s Anixa Biosciences ANIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-147,360
| Closed | -$342K | – | 87 |
|
|
2024
Q4 | $342K | Sell |
147,360
-18,341
| -11% | -$42.6K | 0.01% | 82 |
|
|
2024
Q3 | $522K | Hold |
165,701
| – | – | 0.02% | 80 |
|
|
2024
Q2 | $366K | Hold |
165,701
| – | – | 0.01% | 81 |
|
|
2024
Q1 | $517K | Hold |
165,701
| – | – | 0.03% | 78 |
|
|
2023
Q4 | $643K | Hold |
165,701
| – | – | 0.02% | 85 |
|
|
2023
Q3 | $542K | Hold |
165,701
| – | – | 0.02% | 85 |
|
|
2023
Q2 | $530K | Hold |
165,701
| – | – | 0.02% | 85 |
|
|
2023
Q1 | $713K | Hold |
165,701
| – | – | 0.04% | 83 |
|
|
2022
Q4 | $704K | Hold |
165,701
| – | – | 0.05% | 78 |
|
|
2022
Q3 | $815K | Hold |
165,701
| – | – | 0.08% | 67 |
|
|
2022
Q2 | $507K | Buy |
165,701
+50,000
| +43% | +$153K | 0.05% | 81 |
|
|
2022
Q1 | $317K | Buy |
115,701
+94,404
| +443% | +$259K | 0.04% | 85 |
|
|
2021
Q4 | $63K | Buy |
+21,297
| New | +$63K | 0.01% | 94 |
|